United States · Series B startup

Who invested in Lassen Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$85Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $85MDec 2023
Investors
3
See who backed them

The rounds

  1. Dec 2023

Everyone who backed them

Longitude CapitalVC firm1round
Longwood FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Lassen Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Alta PartnersVC firmPer its own site

Quick answers about Lassen Therapeutics

Who invested in Lassen Therapeutics?

Lassen Therapeutics's investors include Catalio Capital Management, Longitude Capital and Longwood Fund.

How much has Lassen Therapeutics raised?

Lassen Therapeutics has raised $85M across 1 round since 2023.

When did Lassen Therapeutics last raise?

Lassen Therapeutics's most recent round was a Series B of $85M in Dec 2023.

What was Lassen Therapeutics's biggest round?

Its most recent round, $85M in Dec 2023, is also its largest on record.

Who backed Lassen Therapeutics first?

Lassen Therapeutics's first round on record, in Dec 2023, was backed by Catalio Capital Management, Longitude Capital and Longwood Fund.

What stage is Lassen Therapeutics at?

Lassen Therapeutics's latest named round is a Series B, in Dec 2023.

Where is Lassen Therapeutics based?

Lassen Therapeutics is based in the United States.

Companies like Lassen Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.